Clinical Trial

Effects of Individual and Group Education on Mothers' Attitudes and Decisions About Childhood Vaccination

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 7, 2026 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study was planned to determine the effect of face-to-face and group education given to mothers regarding childhood vaccinations on their vaccination attitudes and decisions. It is believed that the education provided will help eliminate mothers' misconceptions and false beliefs about vaccines in the short term, and contribute to positive changes in their attitudes and decisions regarding vaccination. Moreover, it is anticipated that in the long term, this intervention will contribute to achieving better immunization rates and protecting children from vaccine-preventable diseases. This study is also important in terms of emphasizing the role of midwives in protecting and improving infant and community health.This study will be carried out as a randomized controlled experimental study to determine the effect of face-to-face and group education given to mothers regarding childhood vaccinations on their attitudes and decisions about vaccination. Mothers who have children within the age range in which childhood vaccinations are administered will be contacted and informed about the purpose and scope of the study, and they will be asked whether they agree to participate. Mothers who consent to participate will be randomly assigned into three groups using computer-assisted randomization (https://www.random.org/ ): Group 1: Mothers receiving individual face-to-face education, Group 2: Mothers receiving group education, and Group 3: Control group (receiving the routine unit-based information).
Trial Details
NCT Number NCT07324356
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Childhood Immunization
Enrollment 75 participants
Start Date 2025-11-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-07